Owen Mumford Ltd. of Woodstock, Oxfordshire at MEDICA 2018 in Düsseldorf -- COMPAMED Trade Fair
Manufacturers

Owen Mumford Ltd.

Brook Hill, OX20 1TU Woodstock, Oxfordshire
United Kingdom of Great Britain and Northern Ireland

This company is co-exhibitor of
Gambica Association Limited

Hall map

MEDICA 2018 hall map (Hall 3A): stand 3AD02-2

Fairground map

MEDICA 2018 fairground map: Hall 3A

Our range of products

Product categories

  • 03  Diagnostics
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.02  Diagnostic rapid tests

Diagnostic rapid tests

Company news

Date

Topic

Download

Nov 12, 2018

Simplitude™ Pro HIV launch drives early diagnosis of HIV in European market

Owen Mumford, the UK company that has been at the forefront of medical device innovation for over 65 years, is launching the rapid diagnostic HIV test, Simplitude™ Pro HIV (1&2) to European distributors at MEDICA 2018 in Dusseldorf today. 

Owen Mumford’s Senior Product Manager for Diagnostics, Tania MacKenzie says, “Simplitude™ Pro HIV (1&2) is the first rapid diagnostic test with built-in safety lancet, blood collection unit and strip test.  

“The introduction of the Simplitude™ Pro HIV (1&2) rapid diagnosis test at MEDICA, 2018 addresses an important issue, meeting the need for a reliable point-of-care diagnostic test (the overall sensitivity and specificity is 99.6%) that is simple to use, and provides convenient and prompt results to support early diagnosis of HIV.

“Earlier diagnosis enables people with HIV to commence antiretroviral (ART) drug treatment more quickly which improves outcomes, increasing the patient’s chance of living a long and healthy life and reducing the risk of transmission” 

Overall, the European Centre for Disease Prevention and Control estimates that, depending on the country, up to 43% of people living with HIV in Europe remain undiagnosed. On average, 47% of HIV cases are diagnosed late and 28% of people have advanced HIV disease (AHD) where patients can be asymptomatic, or present with an AIDS-defining condition, such as pneumonia. The proportion of people with HIV diagnosed late exceeds 50% in nine European countries, including Italy, Greece and Sweden.[1]  

The Simplitude™ Pro HIV (1&2) is the result of a strategic partnership between Owen Mumford, a leading player in the medical device industry and Atomo Diagnostics, a product design and manufacturing company, based in Australia that specialises in the development of integrated diagnostic test devices.   

The integrated device with built-in lancet and blood collection unit enables the healthcare professional to collect and transfer the correct amount of blood and conduct the steps necessary to perform the test accurately.  This addresses several of the key challenges identified with rapid diagnostic tests (RDTs) such as under collection of blood and complicated instructions which research[2] has been shown to lead to user error. 

Owen Mumford will be demonstrating the Simplitude™ Pro HIV (1&2) throughout MEDICA in Hall 3A – stand 3AD02-2. 

ABOUT OWEN MUMFORD

Owen Mumford is a major healthcare company and device manufacturer that commercialises pioneering medical products in its own brand and custom device solutions for the world’s major pharmaceutical and diagnostic companies.  Owen Mumford’s goal is to enhance access to diagnostics, encourage adherence to treatment and reduce healthcare costs, making a world of difference to a world of people.

For more information, please contact :  Gillian Gibbons, JJ Marketing 07795 342804 or by email om@jjmarketing.co.uk

[1]  European Centre for Disease Prevention and Control HIV testing Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report Available at ecdc.europa.eu/sites/portal/files/documents/HIV%20testing.pdf

[2] Figueroa et al (2018) Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a systematic review and meta-analysis. The lancet HIV. ISSN 2405-4704 DOI: https://doi.org/10.1016/S2352- 3018(18)30044-4

 
 





 

More Less